Avicanna Inc.
AVCNF
$0.25
$0.014.17%
| Weiss Ratings | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.11 | |||
| Price History | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.64% | |||
| 30-Day Total Return | 16.17% | |||
| 60-Day Total Return | 9.65% | |||
| 90-Day Total Return | 20.71% | |||
| Year to Date Total Return | 14.63% | |||
| 1-Year Total Return | -30.94% | |||
| 2-Year Total Return | -6.19% | |||
| 3-Year Total Return | -17.95% | |||
| 5-Year Total Return | -69.46% | |||
| 52-Week High % Change | -53.01% | |||
| 52-Week Low % Change | 85.87% | |||
| Price | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.53 | |||
| 52-Week Low Price | $0.13 | |||
| 52-Week Low Price (Date) | Feb 20, 2025 | |||
| 52-Week High Price (Date) | Mar 20, 2024 | |||
| Valuation | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 28.34M | |||
| Enterprise Value | 33.13M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -53.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.38 | |||
| Price/Book (Q) | 21.01 | |||
| Enterprise Value/Revenue (TTM) | 1.81 | |||
| Price | $0.25 | |||
| Enterprise Value/EBITDA (TTM) | -8.10 | |||
| Enterprise Value/EBIT | -7.19 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 100.82M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 480 University Avenue Toronto, ON M5G 1V2 | |||
| Website | www.avicanna.com | |||
| Country | Canada | |||
| Year Founded | 2016 | |||
| Profitability | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -25.16% | |||
| Profit Margin | -27.29% | |||
| Management Effectiveness | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -17.23% | |||
| Return on Equity | -- | |||
| Income Statement | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 18.30M | |||
| Total Revenue (TTM) | 18.30M | |||
| Revenue Per Share | $0.18 | |||
| Gross Profit (TTM) | 8.21M | |||
| EBITDA (TTM) | -4.09M | |||
| EBIT (TTM) | -4.61M | |||
| Net Income (TTM) | -5.00M | |||
| Net Income Avl. to Common (TTM) | -5.00M | |||
| Total Revenue Growth (Q YOY) | -1.33% | |||
| Earnings Growth (Q YOY) | 45.69% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 53.28% | |||
| Balance Sheet | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 601.10K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 5.95M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 6.80M | |||
| Current Ratio (Q) | 0.832 | |||
| Book Value Per Share (Q) | $0.01 | |||
| Total Assets (Q) | 15.15M | |||
| Total Current Liabilities (Q) | 7.15M | |||
| Total Debt (Q) | 169.70K | |||
| Total Liabilities (Q) | 8.35M | |||
| Total Common Equity (Q) | 1.27M | |||
| Cash Flow | AVCNF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -75.20K | |||
| Cash from Financing (TTM) | 2.70M | |||
| Net Change in Cash (TTM) | 72.30K | |||
| Levered Free Cash Flow (TTM) | -3.67M | |||
| Cash from Operations (TTM) | -2.32M | |||
